Global transcriptomic study of circRNAs expression profile in sorafenib resistant hepatocellular carcinoma cells

The anti-angiogenic drugs represented by sorafenib over the years have always been the first-line treatment of hepatocellular carcinoma (HCC), but the drug resistance has always been a "bottleneck" in curative effect. Recently, aberrant expression of circular RNA (circRNA) is considered to...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Man-ya, Tang, Yan-ping, Liu, Jun-jie, Liang, Rong, Luo, Xiao-ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086252/
https://www.ncbi.nlm.nih.gov/pubmed/32226514
http://dx.doi.org/10.7150/jca.39854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086252/
https://www.ncbi.nlm.nih.gov/pubmed/32226514
http://dx.doi.org/10.7150/jca.39854

Ejemplares similares